Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials

2016/05/01 by Xinfang Xie, Youxia Liu, Vlado Perkovic +8 · 2 citations

paper · doi:10.1053/j.ajkd.2015.10.011

Cited by

• Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community
• How to individualize renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA